|
|
Identification of small molecules for neurological complications of HIV and substance abuse comorbidity |
| 3R01DA046204-05S1 |
|
NIDA |
2022 |
|
|
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection-supplement |
| 3R01DA052845-03S1 |
|
NIDA |
2022 |
|
|
Methamphetamine Effects on Prefrontal Cortical PV+ Interneurons and Resulting Cognitive Deficits |
| 3R01DA054589-02S1 |
|
NIDA |
2022 |
|
|
Alzheimer’s disease and chronic pain |
| 3R21DA053824-02S1 |
|
NIDA |
2022 |
|
|
Using Augmented Reality illusion therapy to develop a non-opioid chronic pain digital treatment |
| 3R43DA053048-01S1 |
|
NIDA |
2022 |
|
|
Facilitating supervised self-management of stimulant medications among adolescents: improving adherence, reducing stigma, and supporting caregivers |
| 3R43DA053121-01A1S1 |
|
NIDA |
2022 |
|
|
Role of ARX mutations in marmoset brain organoids |
| 3U01DA054170-02S1 |
|
NIDA |
2022 |
|
|
Neuroepigenetic mechanisms of chronic low back pain using histone deacetylases PET imaging |
| 4R33DA048485-03 |
|
NIDA |
2022 |
|
|
Opioid-Sparing pain management for Chronic Low Back Pain patients using TMC-CP01 - A VANISH (Virtual Autonomic Neuromodulation Induced Systemic Healing) based program |
| 4R44DA049630-02 |
|
NIDA |
2022 |
|
|
Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder |
| 4UH3DA047714-03 |
|
NIDA |
2022 |